Combined chemotherapy and immunotherapy improves outcomes in PAH
According to a case report published in Pulmonary Circulation, immunotherapy, and chemotherapy used in...
Smartphone app transforms blood pressure monitoring for underserved communities
In a world where cardiovascular disease still ranks highest among all causes of mortality...
European Commission approves yuvanci for pulmonary arterial hypertension treatment
Janssen-Cilag therapy becomes the first single-tablet combination therapy for PAH in Europe Yuvanci, a...